Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC 3-(4-methoxyphenyl)-5-[(5-nitro-2-thienyl)methylene]-2-thioxo-4-thiazolidinone | 346640-08-2 | 98.0% | 378.45 | C15H10N2O4S3 | 25 MG
SDP

Catalog No. 5000214665
Encompass_Preferred

CCF642 is a small-molecule protein disulfide isomerase (PDI) inhibitor reported to have an IC50 of 2.9 μM and to induce endoplasmic reticulum stress and apoptosis in multiple myeloma cells. The compound is supplied for research use with documented solubility and storage guidance for experimental workflows.

  • Potent PDI inhibition with reported IC50 of 2.9 μM.
  • Induces ER stress and apoptosis in multiple myeloma models.
  • High solubility in DMSO for in vitro stock preparation.
  • Stable as a powder under recommended cold storage conditions.
  • Documented in vitro and in vivo formulation guidance for experimental use.

Catalog No. 50-002-14665 Supplier Medchemexpress LLC Supplier No. HY10043025MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

CCF642 is a small-molecule protein disulfide isomerase (PDI) inhibitor reported to have an IC50 of 2.9 μM and to induce endoplasmic reticulum stress and apoptosis in multiple myeloma cells. The compound is supplied for research use with documented solubility and storage guidance for experimental workflows.

  • Potent PDI inhibition with reported IC50 of 2.9 μM.
  • Induces ER stress and apoptosis in multiple myeloma models.
  • High solubility in DMSO for in vitro stock preparation.
  • Stable as a powder under recommended cold storage conditions.
  • Documented in vitro and in vivo formulation guidance for experimental use.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.